Author:
PETRI MICHELLE,SINGH SUKHMINDER,TESFASYONE HANNA,MALIK ASHIMA
Abstract
Objective.We determined the prevalence of and risk factors for British Isles Lupus Activity Group (BILAG) flare in patients with systemic lupus erythematosus (SLE).Methods.We followed 299 patients for 1 year with the BILAG scores calculated using British Lupus Integrated Prospective System software and confirmed with manual calculation.Results.“A” flares occurred at a rate of 0.254/year, “B” flares 1.637/year, and A or B flares 1.765/year. The most common A flares were renal and mucocutaneous. The most common B flares were hematologic, renal, mucocutaneous, and musculoskeletal. Risk factors for a later A or B flare in the hematological system included: low C3 (p < 0.0001), low C4 (p = 0.0004), and positive anti-double-stranded (ds)DNA (p = 0.003); in the mucocutaneous system: low C3 (p = 0.02) and low C4 (p = 0.0004); and in the renal system: low C3 (p = 0.02) and low C4 (p = 0.02). In a stepwise regression model, only ethnicity (p = 0.02) and low C4 (p = 0.0002) remained as independent predictors of later A or 2B flares.Conclusion.The organ system distribution of A and B flares is very different, with A flares more common in renal and mucocutaneous, and B flares more common in hematologic and renal systems. A or 2B flares are significantly more common in African Americans and in patients with abnormal serologies (low C3, low C4, or high anti-dsDNA). If flare is an outcome in an SLE clinical trial, these factors must be balanced by taking them into account at baseline in terms of randomization, or by statistical adjustment in final analyses.
Publisher
The Journal of Rheumatology
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference29 articles.
1. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus;Liang;Arthritis Rheum,1989
2. Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus;Gladman;J Rheumatol,1992
3. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus;Ward;J Rheumatol,2000
4. Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus
5. Validity and reliability of lupus activity measures in the routine clinic setting;Petri;J Rheumatol,1992
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献